A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...

Dr. Kenneth Rosenfield discusses proficiencies required for performing transfemoral carotid artery stenting and how best to ...

"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Nov. 14 -- Comedian Drew Carey's August angioplasty cast a spotlight on a well-known procedure that is seeing new advances to help prevent the renarrowing of the once-blocked arteries. Carey, who ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

View the full release here: "With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland A total of ...

A California company believes it has found a way to alleviate a vexing problem with existing medical stents: the formation of blood clots caused by drug coatings. Conor Medsystems of Menlo Park is ...